Swissmedic approval for Aurobindo's finasteride
This article was originally published in Scrip
Executive Summary
Aurobindo Pharma has received its first approval from Switzerland's medicines regulator, Swissmedic, for finasteride APL tablets 5mg. The product is used for the treatment of symptomatic benign prostatic hyperplasia.